Jun 19, 2012 07:38AM Jefferies Says FDA Request from Amylin (AMLN) Will Not Impact Acquisition Potential

Jun 15, 2012 09:09AM Amylin (AMLN) Wants a Buyout Price At Least in the Low-to-Mid $30s - Jefferies

Apr 5, 2012 08:10AM Jefferies Raises Numbers on Amylin Pharmaceuticals (AMLN) On Upside to Bydureon Sales

Mar 28, 2012 02:42PM Notable 52-Week Highs and Lows of the Day 03/28: (PVH) (AAPL) (DVAX) High; (AONE) (SWSH) (CBK) Low

Mar 28, 2012 12:27PM Streetinsider.com's Hot Lunchtime Reads 03/28: (GLUU) (ELNK) (BBY) (AONE) (AMRN)

Feb 16, 2012 11:01AM Notable Analyst Rating Changes 02/16: (DVN) (EXPD) (HEK) Upgraded; (AMZN) (NVDA) (TLM) Downgraded

Feb 7, 2012 07:40AM Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance

Jan 30, 2012 07:25AM Jefferies Maintains a 'Buy' on Amylin Pharmaceuticals (AMLN); FDA Approves Bydureon With Strong Label

Jan 25, 2012 08:10AM Jefferies Says Amylin Pharmaceuticals (AMLN) Undervalued With Pending Ex-US Partnership for Exenatide

Nov 9, 2011 01:23PM Jefferies Comments on Alkermes (ALKS) Partnership Spilt with Eli Lilly (LLY) and Amylin (AMLN)

Sep 19, 2011 12:20PM Jefferies Comments on Amylin Pharmaceuticals (AMLN) Following EASD Diabetes Meeting

Jul 27, 2011 12:48PM Jefferies Raises Price Target on Amylin Pharmaceuticals (AMLN), Bydureon Back on Track

Jul 8, 2011 09:14AM Jefferies Comments on Amylin (AMLN) Following tQT Results; Sees Approval in Q112

Jul 8, 2011 08:28AM Jefferies Sees Amylin's (AMLN) Bydureon Receiving FDA Approval Following Positive QT Study Results

Jun 27, 2011 10:22AM Jefferies Comments on Amylin Pharm. (AMLN) Following Solid News at ADA

Jan 27, 2011 09:01AM Jefferies Raises Estimates on Amylin Pharmaceuticals (AMLN), Maintains Buy Rating

Jun 18, 2010 10:46AM Notable Analyst Rating Changes 06/18: WMB, AMLN TSO EMN Upgraded; BP, LNCR, SWY, GRS, KR Downgraded

Mar 29, 2010 10:46AM Notable Analyst Rating Changes 03/29: SWN, SVR, CBG, SOLF, SYUT Upgraded; SNV, DRC, TAP, PEET Downgraded

Mar 3, 2010 10:33AM Notable Analyst Rating Changes 03/03: UPS, SLB, INAP, YSI, FCX Upgraded; NFLX, VISN, MDVN, HELE Downgraded

Jan 26, 2010 10:40AM Notable Analyst Rating Changes 01/26: AMLN, PVTB, VLTR, AMAT, SPWRA, NVLS Upgraded; CI, WBD, JCI, GXDX Downgraded

Jan 26, 2010 09:32AM Jefferies & Co Maintains a 'Buy' on Amylin Pharmaceuticals (AMLN); Raises PT

Jan 26, 2010 08:37AM Amlylin Pharma (AMLN): Upgraded to Buy at Citigroup; Street high target of $27

Dec 17, 2009 10:04AM Jefferies & Co Initiates Coverage on Biotechnology and Drugs Stocks

Nov 24, 2009 11:15AM Notable Analyst Rating Changes 11/24: ABG, PRU, RS, AYI, AMLN, TLAB Upgraded; DELL, CIEN, UNP, ALV Downgraded

Jul 22, 2009 09:28AM David Moenning’s Daily State of the Markets: 7/22

Oct 22, 2008 09:29AM David Moenning's Daily State of the Markets: 10/22

Jun 9, 2008 09:45AM Notable Analyst Rating Changes 6/9: MVSN, MUR, ETN Upgraded; AMLN, LL, FTO Downgraded

Jun 9, 2008 09:29AM Pre-Open Movers 06/09: Hilb Rogal & Hobbs (HRH) Surges on Buy, Lehman (LEH) Weak After Massive Loss/Capital Raise

Jun 9, 2008 07:53AM Jefferies Downgrades Amylin Pharmaceuticals (AMLN) to Hold